What Is the Flux Disease? Causes, Symptoms & Treatment

“Flux” is an old English term for dysentery, a severe intestinal infection marked by bloody diarrhea, cramping, and fever. For centuries, the word appeared in medical texts, ship logs, and military records to describe outbreaks that could devastate entire populations. The disease it describes has not vanished. Dysentery still sickens tens of millions of people each year, mainly in low-income countries, and its two primary forms, bacterial and amoebic, remain significant causes of death in young children. What has changed is the name we use and how well we understand what causes it.

Why the Word “Flux” Disappeared from Medicine

From roughly the 14th through the 19th century, English-speaking doctors and laypeople called dysentery “the flux” or “the bloody flux.” The term comes from the Latin fluxus, meaning a flow or discharge, which described the defining symptom: an uncontrollable flow of bloody, mucus-laden stool. Before germ theory existed, “flux” was essentially a symptom label rather than a diagnosis. It covered any illness that produced profuse, bloody diarrhea regardless of the underlying cause. As microbiology advanced in the late 1800s and early 1900s, physicians began distinguishing between different infectious agents and “flux” fell out of medical use, replaced by more precise terms like bacillary dysentery and amoebic dysentery.

Two Different Diseases Under One Old Name

What earlier generations lumped together as “the flux” actually involves two distinct infections with different causes, different organisms, and somewhat different treatment approaches.

Bacillary Dysentery

Bacillary dysentery is caused by Shigella bacteria. Four species are responsible: S. dysenteriae, S. flexneri, S. boydii, and S. sonnei, each with different geographic distributions and severity profiles.¹ Historically, S. flexneri has been regarded as the primary agent of severe dysentery, but S. sonnei is increasingly replacing it, even in developing countries where S. flexneri once dominated.² Shigella spreads through contaminated water, food, or direct person-to-person contact, and it takes a remarkably small number of organisms to cause infection, sometimes as few as ten to a hundred bacteria.

Amoebic Dysentery

Amoebic dysentery is caused by Entamoeba histolytica, a parasitic protozoan that infects the colon and can spread to the liver. The World Health Organization estimates that up to 50 million people are affected by E. histolytica worldwide, and roughly 100,000 die from invasive disease each year, making it the third leading cause of parasitic death globally.³ Not everyone who swallows the parasite gets sick. About 10 to 25% of infected people develop gastrointestinal symptoms as the organisms invade the intestinal lining.³ The rest may carry the parasite without knowing it, potentially spreading it to others.

Recognizing the Symptoms

The symptoms of both forms of dysentery overlap considerably, which is precisely why earlier doctors grouped them under one name. Bacillary dysentery can range from mild watery diarrhea all the way to severe inflammatory disease with fever, intense abdominal cramps, and blood and mucus in the stool.¹ Amoebic dysentery produces a similar picture: abdominal pain, bloody or mucoid diarrhea that can strike ten or more times a day, and fever in about 30% of symptomatic patients.³

Tenesmus, a painful, persistent urge to pass stool even when the bowels are nearly empty, is one of the hallmark symptoms that distinguishes dysentery from ordinary food poisoning or viral gastroenteritis. It results from inflammation in the lower colon and rectum, and it is often what drives patients to seek medical care. In severe cases, symptoms can persist for weeks if untreated.

How Dysentery Damages the Gut

The mechanism differs between the two forms, but both involve destruction of the intestinal lining. Shigella bacteria invade the epithelial cells that line the colon, multiplying inside them and spreading to neighboring cells. The bacteria have evolved specifically to exploit human gut cells, and over time they have become highly efficient at this process.¹ Certain strains, particularly S. dysenteriae type 1, produce Shiga toxin, a potent poison that kills cells by shutting down their ability to make proteins. When the toxin encounters the bacterial cell-wall component lipopolysaccharide, the two work together in a way that amplifies damage beyond what either would cause alone.⁴ This synergistic destruction of cells lining the blood vessels is part of what makes certain strains so dangerous.

Entamoeba histolytica uses a different strategy. Its active form, the trophozoite, physically destroys human cells and burrows into the intestinal wall, creating ulcers. In severe cases the parasites can penetrate through the bowel wall entirely or travel through the bloodstream to the liver, where they form abscesses. The parasite’s name literally means “tissue destroyer,” and that is a fair description of what it does.

Dangerous Complications

For most otherwise healthy adults, dysentery is miserable but self-limiting with proper care. The real danger lies in two areas: dehydration and organ damage from toxins.

Dehydration is the most immediate threat. Severe diarrhea strips the body of water and electrolytes rapidly. In a study of patients with severe acute diarrhea treated using the WHO rehydration protocol, about 78% of those who arrived with low potassium levels did not have their potassium corrected during hospitalization and needed additional intervention.⁵ Electrolyte imbalances, particularly low potassium, can cause muscle weakness, heart rhythm problems, and in extreme cases, cardiac arrest. This is a reminder that rehydration is not as simple as drinking water; replacing lost salts matters as much as replacing lost fluid.

The most feared complication of Shigella dysentery is hemolytic uremic syndrome, or HUS. This condition involves destruction of red blood cells, a drop in the platelets that help blood clot, and kidney failure. It occurs in roughly 13% of dysentery patients infected with S. dysenteriae type 1, mostly in children under five in Africa and Asia.⁶ The risk increases when the wrong antibiotics are used, ones the bacteria are resistant to, or when any antibiotic treatment is delayed more than four days after diarrhea begins.⁶ In one outbreak of S. dysenteriae type 1 in South Africa, 107 cases of HUS were documented over roughly 18 months.⁷ Shiga toxin drives this complication by entering endothelial cells in the kidneys and other organs, triggering massive cell death and activating clotting within capillaries.⁸

Amoebic dysentery carries its own severe complication: toxic megacolon, where the colon becomes massively distended and can perforate. This is a surgical emergency. In some cases, the amoebae also travel to the liver and form large abscesses that require drainage.

Getting the Right Diagnosis

Because “flux” was a blanket term for bloody diarrhea, it was useless for guiding treatment. Modern diagnosis aims to identify the specific organism responsible, which matters because the treatment for bacterial dysentery (antibiotics) is different from the treatment for amoebic dysentery (antiparasitic drugs), and giving the wrong one wastes time.

Traditional stool testing, which involves culturing bacteria from a stool sample, catches the causative organism less than half the time. Newer multiplex PCR testing, which scans for the genetic material of many pathogens simultaneously, performs substantially better. In one hospital comparison, PCR testing identified a pathogen in about 78% of cases versus 41% with conventional methods, and it picked up mixed infections (more than one pathogen at once) about a third of the time.⁹ That same study found PCR testing also reduced inappropriate antibiotic use, shortened the duration of antibiotic therapy, and increased the rate at which doctors adjusted or stopped antibiotics based on actual results.⁹

Diagnosis also requires ruling out noninfectious causes. Ulcerative colitis and Crohn’s disease can look strikingly similar to infectious dysentery, with bloody diarrhea, abdominal pain, and inflamed colon tissue on examination. Distinguishing features include the pattern of inflammation (diffuse and uniform in ulcerative colitis, patchy in some infections), the patient’s age, how well they respond to antibiotics, and biopsy findings. Bloody diarrhea in a young adult who does not improve with antibiotics should raise suspicion for inflammatory bowel disease rather than infection.¹⁰

Treatment Today

The cornerstone of treating any form of dysentery is replacing lost fluids and electrolytes. Oral rehydration solutions, which the WHO has championed for decades, remain the single most important intervention. The current WHO-approved formulation uses a reduced osmolarity of 250 mOsm/L or less, which decreases episodes of vomiting and the need for intravenous fluids.¹¹ For patients too sick to drink or with severe dehydration, intravenous fluids are necessary.

Beyond rehydration, treatment depends on the cause. Bacillary dysentery caused by Shigella usually warrants antibiotics, especially in moderate to severe cases. The choice of antibiotic is increasingly complicated by drug resistance, discussed below. Amoebic dysentery requires a specific antiparasitic drug, typically metronidazole or tinidazole, to kill the trophozoites, followed by a luminal agent like paromomycin to clear any cysts remaining in the intestine. Skipping that second step is a common error that leads to relapse.

One important caution: antidiarrheal drugs that slow gut motility, like loperamide, are generally avoided in dysentery. When the diarrhea is caused by an invasive organism that is destroying the gut lining, slowing the passage of stool can trap the pathogen and its toxins inside the body, worsening the damage.

The Drug Resistance Problem

This is arguably the most alarming aspect of modern dysentery. Shigella species have developed resistance to multiple drug classes, and the problem is accelerating. Multidrug-resistant S. sonnei is increasing globally,¹² and extensively drug-resistant strains, meaning bacteria resistant to nearly all standard oral antibiotics, have emerged in Europe and elsewhere. In France, extensively drug-resistant S. sonnei appeared rapidly enough to prompt public health alerts, with treatment options narrowed to just a few drugs like pivmecillinam or fosfomycin for oral therapy, and carbapenems (a last-resort class of intravenous antibiotics) for hospitalized patients.¹³

In England, extensively drug-resistant S. flexneri carrying specific resistance genes has emerged among men who have sex with men, with epidemiological and genetic evidence suggesting that resistance elements are being shared between Shigella species through horizontal gene transfer.¹⁴ This means resistance can jump between bacterial strains and species, spreading the problem faster than new antibiotics can be developed. The practical consequence for patients is that a doctor cannot simply prescribe a standard antibiotic for Shigella anymore without knowing the local resistance patterns, and in some cases, stool cultures with susceptibility testing are needed to find a drug that will actually work.

Why There Is Still No Vaccine

Given how common and how dangerous dysentery remains, the absence of an approved Shigella vaccine might seem surprising. The obstacle is not lack of effort. Researchers have been working on Shigella vaccines for more than 50 years, producing numerous candidates that have shown promise but none that have reached widespread use.¹⁵ Several factors make it unusually difficult. Shigella has four species and dozens of serotypes, so a vaccine that protects against one may not protect against the others. Scientists still do not have a clearly defined marker that tells them when someone is immune. And running efficacy trials in the high-burden settings where a vaccine is most needed is logistically grueling.

Next-generation vaccine platforms are in advanced clinical testing and offer better prospects for broad protection across serotypes.¹⁶ But even if a highly effective vaccine emerges, getting it widely adopted faces practical hurdles. Infant immunization schedules in low- and middle-income countries are already crowded with high-priority vaccines, diarrheal disease mortality rates are declining due to improved sanitation and oral rehydration, and adding another required dose is expensive.¹⁷ A combination vaccine that protects against Shigella alongside other common childhood infections would help, but developing one adds years of complexity.

Long-Term Effects After Recovery

Even after the acute illness resolves, dysentery can leave lasting marks. Research using controlled human infection models has found that people who developed shigellosis had persistent changes in their gut microbiome after clinical recovery, while those exposed but not sickened bounced back to their pre-infection gut composition. The changes included a decrease in beneficial bacteria like Faecalibacterium and an increase in species associated with gut inflammation.¹⁸ These shifts are linked to increased risk of chronic problems after the infection clears, including irritable bowel syndrome, reactive arthritis, and altered gut permeability.¹⁸

The consequences for children are especially concerning. Repeated episodes of diarrheal illness in early childhood are associated with stunted growth, and stunting itself is linked to lower cognitive scores years later. One study found that early childhood diarrhea predicted reduced cognitive performance on standardized tests independently of malnutrition, suggesting that infection may damage developing brains through pathways beyond simple nutritional deprivation.¹⁹ The evidence here is not perfectly uniform; a multi-site study found that diarrhea episodes themselves were not a significant predictor of cognitive scores once growth stunting was accounted for, though stunting itself was strongly and consistently linked to lower cognition across all sites.²⁰ Either way, the message is the same: preventing dysentery in young children is not just about avoiding a week of misery. It can shape physical and mental development for years.

Prevention Without a Vaccine

In the absence of a vaccine, preventing dysentery relies on interrupting transmission. The classic public health prescription is clean water, sanitation, and handwashing. This sounds simple, and at a population level it has worked: diarrheal deaths have dropped dramatically in countries that have built reliable water and sewage infrastructure. But the relationship between specific sanitation interventions and measurable reductions in fecal contamination is surprisingly murky in research. A systematic review of sanitation impact found little to no measurable effect of sanitation programs on water quality, hand contamination, food contamination, or soil contamination, with only a small effect on observations of visible feces and some evidence of reduced fly populations.²¹

That does not mean sanitation does not work. It means measuring its effect through intermediate indicators like surface contamination is hard, and that partial sanitation improvements in communities where fecal exposure comes from many routes may not show clean results in short-term studies. The historical evidence from industrialized nations is overwhelming: building sewers and treating water eliminated dysentery as a mass killer long before antibiotics existed. For travelers visiting high-risk areas, the practical advice remains straightforward: drink only treated or bottled water, avoid raw vegetables washed in local water, wash your hands frequently, and peel fruit yourself. These measures are not glamorous, but they work at the individual level even when population-level sanitation is incomplete.